DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactOrders & Deals

Viyash Scientific Limited — Update-Acquisition of 'to be incorporated companies'-XBRL

NSE 1 hr ago·2 Nov 2026, 12:13 pm

Viyash Scientific

Viyash Scientific Limited has informed stock exchanges that it is acquiring companies that are yet to be incorporated. This strategic move involves a scheme of arrangement, which is a formal process to restructure the company's assets and liabilities.

For investors, this development suggests Viyash is preparing for significant corporate restructuring or expansion. While the specific details of the target companies remain undisclosed, such schemes are often undertaken to streamline operations or acquire new capabilities. It is important to monitor the official filings for more clarity on the deal's valuation and the strategic rationale behind the acquisition.